CSIMarket
 


Scpharmaceuticals Inc   (SCPH)
Other Ticker:  
 
 

SCPH's EPS Net Growth by Quarter and Year

Scpharmaceuticals Inc 's EPS Net results by quarter and year




SCPH EPS Net (in $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -0.27 -0.28 -0.58
III Quarter September -0.37 -0.24 -0.33 -0.33
II Quarter June -0.35 -0.26 -0.36 -0.39
I Quarter March -0.28 -0.26 -0.35 -0.47
FY   -1.00 -1.03 -1.32 -1.77



SCPH EPS Net third quarter 2022 Y/Y Growth Comment
Scpharmaceuticals Inc in the third quarter 2022 recorded EPS net loss of $ -0.37 .

According to the results reported in the third quarter 2022, Scpharmaceuticals Inc achieved the best EPS Net growth in Major Pharmaceutical Preparations industry. While Scpharmaceuticals Inc ' s EPS Net no change of % ranks overall at the positon no. in the third quarter 2022.




SCPH EPS Net ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Scpharmaceuticals Inc 's third quarter 2022 EPS Net $ -0.37 SCPH's Income Statement
Scpharmaceuticals Inc 's third quarter 2021 EPS Net $ -0.24 Quarterly SCPH's Income Statement
New: More SCPH's historic EPS Net Growth >>


SCPH EPS Net (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS Net third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS Net third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS Net by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Scpharmaceuticals Inc 's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SCPH's III. Quarter Q/Q EPS Net Comment
Current accomplishment of -0.37 by Scpharmaceuticals Inc appear even less good compare to the -0.35 a quarter before.

Within Major Pharmaceutical Preparations industry Scpharmaceuticals Inc achieved highest sequential EPS Net growth. While Scpharmaceuticals Inc 's EPS Net growth quarter on quarter, overall rank is .


EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SCPH's III. Quarter Q/Q EPS Net Comment
Current results of -0.37 by Scpharmaceuticals Inc appear even worse if you take a look at EPS net loss -0.35 in the previous quarter.

Within Major Pharmaceutical Preparations industry Scpharmaceuticals Inc achieved highest sequential EPS Net growth. While Scpharmaceuticals Inc 's EPS Net growth quarter on quarter, overall rank is .


Scpharmaceuticals Inc 's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative EPS Net 12 Months Ending $ -1.27 $ -1.14 $ -1.05 $ -1.03 $ -1.04
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) - - - - -
Seq. EPS Net Growth (TTM) Overall Ranking # # # # #




Cumulative EPS Net growth Comment
Scpharmaceuticals Inc ' has realized cumulative trailing twelve months EPS net loss of $ -1 in the Sep 30 2022 period.
The business is getting worse as the cumulative EPS net loss is inflating from $ -1.14 for the period from Jun 30 2022 to Sep 30 2021 and $ -0.35 for the twelve months ending in the quarter Sep 30 2021 Alexander  Davies wrote.

Scpharmaceuticals Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative EPS Net growth Comment
Scpharmaceuticals Inc ' has realized cumulative trailing twelve months EPS net loss of $ -1 in the Sep 30 2022 period.
The situation is getting worse as the cumulative EPS net loss is getting bigger from $ -1.14 in the twelve months ending a quarter before and $ -0.35 for the twelve months ending in the quarter a year ago Alexander  Davies mentioned.

Scpharmaceuticals Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other EPS Net Growth
Major Pharmaceutical Preparations Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
SCPH's EPS Net Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for SCPH's Competitors
EPS Net Growth for Scpharmaceuticals Inc 's Suppliers
EPS Net Growth for SCPH's Customers

You may also want to know
SCPH's Annual Growth Rates SCPH's Profitability Ratios SCPH's Asset Turnover Ratio SCPH's Dividend Growth
SCPH's Roe SCPH's Valuation Ratios SCPH's Financial Strength Ratios SCPH's Dividend Payout Ratio
SCPH's Roa SCPH's Inventory Turnover Ratio SCPH's Growth Rates SCPH's Dividend Comparisons



Companies with similar EPS Net no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Sep 30 2022
Stryker Corp87.72%$ 87.719 
Abiomed Inc 87.10%$ 87.097 
Carlisle Companies Incorporated80.90%$ 80.899 
Universal Security Instruments Inc80.00%$ 80.000 
Medpace Holdings Inc 58.91%$ 58.915 
Vir Biotechnology Inc 58.54%$ 58.537 
United Therapeutics Corporation43.57%$ 43.567 
Iradimed Corporation35.00%$ 35.000 
Zimmer Biomet Holdings Inc 33.33%$ 33.333 
Royalty Pharma Plc33.33%$ 33.333 
Eli Lilly And Company31.97%$ 31.967 
Bio techne Corp30.77%$ 30.769 
Merit Medical Systems Inc28.57%$ 28.571 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PTWOU's Profile

Stock Price

PTWOU's Financials

Business Description

Fundamentals

Charts & Quotes

PTWOU's News

Suppliers

PTWOU's Competitors

Customers & Markets

Economic Indicators

PTWOU's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071